Enfoque terapéutico individualizado en el tratamiento de hipertensión arterial secundaria a estenosis renal
DOI:
https://doi.org/10.47464/MetroCiencia/vol30/Suppl1/2022/20-22Keywords:
hipertensión arterial, dislipidemia, hiperuricemia, obesidad Grado IIAbstract
Paciente masculino, 33 años, con hipertensión arterial, dislipidemia, hiperuricemia, obesidad Grado II, resistencia a la insulina. Acude para biopsia de lesión tumoral, presenta crisis hipertensiva. Se suspende el procedimiento. Se inicia abordaje diagnóstico de HTA secundaria en el contexto de este paciente.
Downloads
References
Bakris G, Ali W, Parati G. ACC/AHA Versus ESC/ESH on Hypertension Guidelines. Journal of the American College of Cardiology. 2019 Jun;73(23):3018–26.
Colyer WR, Eltahawy E, Cooper CJ. Renal artery stenosis: Optimizing diagnosis and treatment. Progress in cardiovascular diseases [Internet]. 2011;54(1):29–35. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801483/#
Kramer HJ, Townsend RR, Griffin K, Flynn JT, Weiner DE, Rocco MV, et al. KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline. American Journal of Kidney Diseases. 2019 Apr;73(4):437–58.
Parikh SA, Shishehbor MH, Gray BH, White CJ, Jaff MR. SCAI expert consensus statement for renal artery stenting appropriate use. Catheterization and Cardiovascular Interventions. 2014 Aug 19;84(7):1163–71.
Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, et al. Stenting and Medical Therapy for Atherosclerotic Renal-Artery Stenosis. New England Journal of Medicine. 2014 Jan 2;370(1):13–22.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Gabriela León-Molina, Tanya Padilla

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.


